RESPONSE TO NEOADYAVANT CHEMOTHERAPY WITH PLATINUM-BASED DRUGS IN BREAST CANCER PATIENTS WITH BRCA1 DELETION IN TUMOR

Currently, the presence of the germinal mutation BRCA1 5382insC in breast cancer patients is one of the determining factors for prescribing platinum-based drugs. However, this type of mutation is found in no more than 10 % of patients, thus limiting the feasibility of administering platinum-based dr...

詳細記述

書誌詳細

主要な著者:	M. M. Tsyganov, N. A. Tarabanovskaya, I. V. Deryusheva, M. K. Ibragimova, P. V. Kazantseva, A. M. Pevzner, E. M. Slonimskaya, N. V. Litviakov
フォーマット:	Artigo
言語:	Russo
出版事項:	Russian Academy of Sciences, Tomsk National Research Medical Center 2019-06-01
シリーズ:	Сибирский онкологический журнал
主題:	breast cancer brca1 microarray analysis digital drop pcr neoadjuvant chemotherapy personalized treatment
オンライン･アクセス:	https://www.siboncoj.ru/jour/article/view/1103
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!